Devices Agency has updated the Guideline on the Scheduling Processes for Marketing Authorization Applications of Medicinal Products for Human Use, the Guideline on Biosimilar Medicinal Products, and the Guideline on the Importation of Medicines from Abroad
29 Aug 2024
One of the most significant updates in the Guideline on the Scheduling Processes for Marketing Authorization Applications of Medicinal Products for Human Use (“Scheduling Guideline”) is the new regulations regarding hybrid applications. Firstly, the Scheduling Guideline has been updated […]

